Does LENALIDOMIDE Cause Malignant neoplasm progression? 1,150 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,150 reports of Malignant neoplasm progression have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.3% of all adverse event reports for LENALIDOMIDE.
1,150
Reports of Malignant neoplasm progression with LENALIDOMIDE
0.3%
of all LENALIDOMIDE reports
295
Deaths
202
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LENALIDOMIDE?
Of the 1,150 reports, 295 (25.7%) resulted in death, 202 (17.6%) required hospitalization, and 44 (3.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 1,150 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LENALIDOMIDE Alternatives Have Lower Malignant neoplasm progression Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE